Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-14 Sale | 2022-11-16 4:19 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 31,515 | $13.88 | $437,428 | 298,541 (Direct) | View |
| 2022-03-07 Sale | 2022-03-09 4:24 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 20,000 | $17.16 | $343,200 | 230,056 (Direct) | View |
| 2021-12-07 Sale | 2021-12-09 4:38 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 30,100 | $12.2 | $367,220 | 215,056 (Direct) | View |
| 2019-11-18 Purchase | 2019-11-18 4:03 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 25,000 | $1.45 | $36,250 | 155,587 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-14 Exercise | 2022-11-16 4:19 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 50,000 | $1.42 | 298,541 (Direct) | View |
| 2022-11-14 Exercise | 2022-11-16 4:19 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 100,000 | $0 | 298,541 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 5:09 pm | 2022-12-14 2031-12-14 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 199,000 | $0 | 414,056 (Direct) | View |
| 2021-12-07 Exercise | 2021-12-09 4:38 pm | 2013-03-01 2022-03-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 62,000 | $0 | 215,056 (Direct) | View |
| 2021-12-07 Exercise | 2021-12-09 4:38 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer | 62,000 | $4.73 | 215,056 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 4:25 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 50,000 | $4.15 | 183,156 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 4:25 pm | 2012-03-01 2021-03-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 50,000 | $0 | 183,156 (Direct) | View |
| 2021-02-19 Tax Withholding | 2021-02-23 4:25 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 22,431 | $11.53 | 183,156 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-17 4:30 pm | 2021-12-15 2030-12-15 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 280,000 | $0 | 280,000 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 4:19 pm | 2020-12-03 2023-08-08 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 17,000 | $0 | 17,000 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 4:42 pm | 2020-02-21 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 18,000 | $0 | 18,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 5:03 pm | 2020-02-14 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 31,500 | $0 | 31,500 (Direct) | View |
| 2019-12-17 Option Award | 2019-12-19 5:52 pm | 2020-12-17 2029-12-17 | BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery | 225,000 | $0 | 225,000 (Direct) | View |